肝硬化的转录和代谢分析
Xiao Kuang1,2, Jinyu Li1, Yiheng Xu1
1Department of Clinical Laboratory, Yunnan Molecular Diagnostic Center, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Combinatorial chemistry & high throughput screening
|July 18, 2023
概括
这项研究揭示了肝硬化的主要分子机制和生物标志物,使用转录组和代谢组测序. 结果确定差异表达的基因,microRNA和代谢物,以提高诊断效率和了解疾病途径.
科学领域:
- 基因组学和代谢学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝硬化显著减少了全球预期寿命.
- 驱动肝硬化的精确分子机制尚未完全理解.
- 这项研究旨在通过综合的奥米克分析来阐明这些机制.
研究的目的:
- 探索与肝硬化相关的基因,途径和相互作用.
- 为了确定肝硬化新型诊断生物标志物.
- 揭示肝硬化背后的独特生物机制.
主要方法:
- 来自肝硬化患者和健康对照者的血液样本的转录组和代谢组测序.
- 通过实时定量聚合酶链反应验证差异表达的微RNA (miRNA) 和信使RNA (mRNA).
- 生物信息分析包括路径丰富,网络分析和接收器运行特征 (ROC) 曲线分析.
主要成果:
- 在肝硬化患者中鉴定差异表达的miRNA和mRNA.
- 发现了五种显著丰富的代谢途径和关键的差异性代谢产物.
- 用ROC曲线分析证明已识别的代谢物的诊断疗效.
- 探索转录基因组-代谢基因组联系和潜在的共同途径.
结论:
- 测序和生物信息学确定了与肝硬化相关的特定miRNA和基因.
- 发现了独特的生物机制和疾病特异性网络.
- 确定了具有诊断潜力的新生物标志物,并为未来研究提出了常见的转录组-代谢组途径.
相关概念视频
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


